Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy

American Psychiatric Association, 1994 Castanon, 2002, Effects of antidepressants on cytokine production and actions, Brain Behav Immun, 16, 569, 10.1016/S0889-1591(02)00008-9 Chang, 1991, Suppressive effects of alprazolam on the immune response of mice, Int J Immunopharmacol, 13, 259, 10.1016/0192-0561(91)90106-H Drevon, 2005, Fatty acids and expression of adipokines, Biochim Biophys Acta, 1740, 287, 10.1016/j.bbadis.2004.11.019 Frank, 1991, Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence, Arch Gen Psychiatry, 48, 851, 10.1001/archpsyc.1991.01810330075011 Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Himmerich, 2004, Early prediction of changes in weight during six weeks of treatment with antidepressants, J Psychiatr Res, 38, 485, 10.1016/j.jpsychires.2004.02.002 Hinze-Selch, 2000, Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine, Neuropsychopharmacology, 23, 13, 10.1016/S0893-133X(00)00089-0 Iacobellis, 2005, Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease, Cytokine, 29, 251 Kalashnikov, 2002, Immunomodulating effects of tofizopam (Grandaxin) and diazepam in vitro, Mediat Inflamm, 11, 53, 10.1080/09629350210309 Kenis, 2002, Effects of antidepressants on the production of cytokines, Int J Neuropsychopharmacol, 5, 401, 10.1017/S1461145702003164 Kita, 2005, Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha, Biochem Biophys Res Commun, 331, 484, 10.1016/j.bbrc.2005.03.205 Kraus, 2002, Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine, Pharmacopsychiatry, 35, 220, 10.1055/s-2002-36390 Lara, 2003, Paroxetine-induced increase in metabolic end products of nitric oxide, J Clin Psychopharmacol, 23, 641, 10.1097/01.jcp.0000085416.08426.1d Maes, 2001, The immunoregulatory effects of antidepressnts, Hum Psychopharmacol Clin Exp, 16, 95, 10.1002/hup.191 Matsuda, 2002, Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis, J Biol Chem, 277, 37487, 10.1074/jbc.M206083200 Miller, 1999, Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression, Adv Exp Med Biol, 461, 107, 10.1007/978-0-585-37970-8_7 Mocellin, 2003, The dual role of IL-10, Trends Immunol, 24, 36, 10.1016/S1471-4906(02)00009-1 Ouchi, 1999, Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin, Circulation, 100, 2473, 10.1161/01.CIR.100.25.2473 Ouchi, 2001, Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages, Circulation, 103, 1057, 10.1161/01.CIR.103.8.1057 Ross, 1999, Atherosclerosis — an inflammatory disease, Engl J Med, 340, 115, 10.1056/NEJM199901143400207 Schiepers, 2005, Cytokines and major depression, Prog Neuropsychopharmacol Biol Psychiatry, 29, 201, 10.1016/j.pnpbp.2004.11.003 Schlatter, 2001, Differences in interleukins' patterns between dysthymia and major depression, Eur Psychiatry, 16, 317, 10.1016/S0924-9338(01)00585-5 Shimada, 2004, Adiponectin and atherosclerotic disease, Clin Chim Acta, 344, 1, 10.1016/j.cccn.2004.02.020 Taylor, 2005, Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction, Arch Gen Psychiatry, 62, 792, 10.1001/archpsyc.62.7.792 Tentolouris, 2004, Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy, Int J Cardiol, 94, 301, 10.1016/j.ijcard.2003.08.002 Tuglu, 2003, Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder, Psychopharmacology, 170, 429, 10.1007/s00213-003-1566-z Xia, 1996, Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells, Immunopharmacology, 34, 27, 10.1016/0162-3109(96)00111-7